Husam Abdel-Qadir1,2,3,4, Jiming Fang3, Douglas S Lee2,3,4, Jack V Tu3,4,5, Eitan Amir3,4,6, Peter C Austin3,4, Geoffrey M Anderson3,4. 1. Department of Medicine, Women's College Hospital, Toronto, ON, Canada (H.A.-Q.). h.abdel.qadir@mail.utoronto.ca. 2. Division of Cardiology, Peter Munk Cardiac Centre and the Ted Rogers Centre for Heart Research, University Health Network, Toronto, ON, Canada (H.A.-Q., D.S.L.). 3. Institute for Clinical Evaluative Sciences, Toronto, ON, Canada (H.A.-Q., J.F., D.S.L., J.V.T., E.A., P.C.A., G.M.A.). 4. Institute of Health Policy, Management, and Evaluation, University of Toronto, ON, Canada (H.A.-Q., D.S.L., J.V.T., E.A., P.C.A., G.M.A.). 5. Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, ON, Canada (J.V.T.). 6. Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada (E.A.).
Abstract
BACKGROUND: Ignoring competing risks in time-to-event analyses can lead to biased risk estimates, particularly for elderly patients with multimorbidity. We aimed to demonstrate the impact of considering competing risks when estimating the cumulative incidence and risk of stroke among elderly atrial fibrillation patients. METHODS AND RESULTS: Using linked administrative databases, we identified patients with atrial fibrillation aged ≥66 years discharged from hospital in ON, Canada between January 1, 2007, and March 31, 2011. We estimated the cumulative incidence of stroke hospitalization using the complement of the Kaplan-Meier function and the cumulative incidence function. This was repeated after stratifying the cohort by presence of prespecified comorbidities: chronic kidney disease, chronic obstructive pulmonary disease, cancer, or dementia. The full cohort was used to regress components of the CHA2DS2VASc (congestive heart failure, hypertension, age, diabetes mellitus, stroke, vascular disease, sex) score on the hazard of stroke hospitalization using the Fine-Gray and Cox methods. These models were subsequently used to predict the 5-year risk of stroke hospitalization. Among 136 156 patients, the median CHA2DS2VASc score was 4 and 84 728 patients (62.2%) had ≥1 prespecified comorbidity. The 5-year cumulative incidence of stroke was 5.4% (95% confidence interval, 5.3%-5.5%), whereas that of death without stroke was 48.8% (95% confidence interval, 48.5%-49.1%). The incidence of both events was overestimated by the Kaplan-Meier method; stroke incidence was overestimated by a relative factor of 39%. The degree of overestimation was larger among patients with non-CHA2DS2VASc comorbidity because of higher incidence of death without stroke. The Fine-Gray model demonstrated better calibration than the Cox model, which consistently overpredicted stroke incidence. CONCLUSIONS: The incidence of death without stroke was 9-fold higher than that of stroke, leading to biased estimates of stroke risk with traditional time-to-event methods. Statistical methods that appropriately account for competing risks should be used to mitigate this bias.
BACKGROUND: Ignoring competing risks in time-to-event analyses can lead to biased risk estimates, particularly for elderly patients with multimorbidity. We aimed to demonstrate the impact of considering competing risks when estimating the cumulative incidence and risk of stroke among elderly atrial fibrillationpatients. METHODS AND RESULTS: Using linked administrative databases, we identified patients with atrial fibrillation aged ≥66 years discharged from hospital in ON, Canada between January 1, 2007, and March 31, 2011. We estimated the cumulative incidence of stroke hospitalization using the complement of the Kaplan-Meier function and the cumulative incidence function. This was repeated after stratifying the cohort by presence of prespecified comorbidities: chronic kidney disease, chronic obstructive pulmonary disease, cancer, or dementia. The full cohort was used to regress components of the CHA2DS2VASc (congestive heart failure, hypertension, age, diabetes mellitus, stroke, vascular disease, sex) score on the hazard of stroke hospitalization using the Fine-Gray and Cox methods. These models were subsequently used to predict the 5-year risk of stroke hospitalization. Among 136 156 patients, the median CHA2DS2VASc score was 4 and 84 728 patients (62.2%) had ≥1 prespecified comorbidity. The 5-year cumulative incidence of stroke was 5.4% (95% confidence interval, 5.3%-5.5%), whereas that of death without stroke was 48.8% (95% confidence interval, 48.5%-49.1%). The incidence of both events was overestimated by the Kaplan-Meier method; stroke incidence was overestimated by a relative factor of 39%. The degree of overestimation was larger among patients with non-CHA2DS2VASc comorbidity because of higher incidence of death without stroke. The Fine-Gray model demonstrated better calibration than the Cox model, which consistently overpredicted stroke incidence. CONCLUSIONS: The incidence of death without stroke was 9-fold higher than that of stroke, leading to biased estimates of stroke risk with traditional time-to-event methods. Statistical methods that appropriately account for competing risks should be used to mitigate this bias.
Authors: Rashmi K Murthy; Juhee Song; Akshara S Raghavendra; Yisheng Li; Limin Hsu; Kenneth R Hess; Carlos H Barcenas; Vicente Valero; Robert W Carlson; Debu Tripathy; Gabriel N Hortobagyi Journal: NPJ Breast Cancer Date: 2020-03-25
Authors: Arjun Sinha; Hongyan Ning; Mercedes R Carnethon; Norrina B Allen; John T Wilkins; Donald M Lloyd-Jones; Sadiya S Khan Journal: Circ Heart Fail Date: 2021-03-25 Impact factor: 8.790
Authors: Nayana F A Gomes; Vicente Rezende Silva; Robert A Levine; William A M Esteves; Marildes Luiza de Castro; Livia S A Passos; Jacob P Dal-Bianco; Alexandre Negrão Pantaleão; Jose Luiz Padilha da Silva; Timothy C Tan; Walderez O Dutra; Elena Aikawa; Judy Hung; Maria Carmo P Nunes Journal: Front Cardiovasc Med Date: 2022-03-11
Authors: Husam Abdel-Qadir; Paaladinesh Thavendiranathan; Kinwah Fung; Eitan Amir; Peter C Austin; Geoffrey S Anderson; Douglas S Lee Journal: JAMA Netw Open Date: 2019-09-04
Authors: Husam Abdel-Qadir; Paaladinesh Thavendiranathan; Peter C Austin; Douglas S Lee; Eitan Amir; Jack V Tu; Kinwah Fung; Geoffrey M Anderson Journal: J Natl Cancer Inst Date: 2019-08-01 Impact factor: 13.506